Skip to main content

Granules India

Granules India Ltd is an Indian multinational pharmaceutical manufacturing enterprise specializing in the research, development, production, and global wholesale distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), and finished dosage formulations (FDFs), prominently featuring high-volume analgesic, anti-diabetic, anti-coagulant, and anti-infective drug products supplied to global pharmaceutical brands and healthcare distributors across North America, Europe, Latin America, and Asia. The company operates advanced USFDA-compliant chemical synthesis and finished dosage manufacturing complexes in India. Its core business operations encompass API synthesis, pharmaceutical intermediate manufacturing, finished dosage formulation, and international wholesale distribution. Revenue is derived directly from the global wholesale sale of APIs and pharmaceutical formulations to global drug manufacturers. Granules India holds a leading global market position in high-volume pharmaceutical active ingredients and finished dosage manufacturing. The company is headquartered in Hyderabad, Telangana, India, and its equity shares trade on the National Stock Exchange of India and BSE Limited.

2 of the funds FundTelligence covers report a position in Granules India.

Legal name
Granules India Ltd
Sector
Health Care
Country
India
Funds holding it
2

Funds holding Granules India

Loading...